Wilson Sonsini Goodrich & Rosati advised 858 Therapeutics on intellectual property matters related to the transaction. 858 Therapeutics announced raising $50 million in a Series B...
Wilson Sonsini Goodrich & Rosati advised 858 Therapeutics on intellectual property matters related to the transaction. 858 Therapeutics announced raising $50 million in a Series B...
You must be a Standard 1 Year member to access this content.